Loading...
Loading...
Browse all stories on DeepNewz
VisitHow will 4DMT's stock price change within one week after Phase 3 trial results announcement?
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Stock market data from financial news or stock trading platforms
4D Molecular Announces Positive Results for 4D-150 Wet-AMD Gene Therapy
Sep 18, 2024, 08:08 PM
4D Molecular Therapeutics (4DMT) has announced positive results in the development of a gene therapy for wet age-related macular degeneration (wet-AMD), a leading cause of age-related blindness. The therapy, known as 4D-150, has shown robust and durable clinical activity. Notably, only two out of 71 dosed patients have exhibited signs of ocular inflammation. The company has also outlined the design for its upcoming Phase 3 program, known as 4FRONT, during the 4D-150 Wet AMD Development Day. This progress highlights the ongoing advancements in gene therapy, particularly in treatments for common conditions like wet-AMD.
View original story
Increase > 20% • 25%
Increase 10-20% • 25%
Increase < 10% • 25%
Decrease • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Increases by more than 10% • 25%
Increases by 0-10% • 25%
Decreases by 0-10% • 25%
Decreases by more than 10% • 25%
Increase by more than 20% • 25%
Increase by 10% to 20% • 25%
Change less than 10% • 25%
Decrease • 25%
Increase by more than 20% • 25%
Increase by 10-20% • 25%
No significant change • 25%
Decrease • 25%
Stock price increases by over 20% • 25%
Stock price increases by 10-20% • 25%
Stock price changes by less than 10% • 25%
Stock price decreases • 25%
Increase by 5% or more • 25%
Increase by less than 5% • 25%
Decrease • 25%
No significant change • 25%
Increase over 20% • 25%
Increase 0-20% • 25%
No change • 25%
Decrease • 25%
Increases by more than 10% • 25%
Decreases by more than 10% • 25%
Changes by less than 10% • 25%
No significant change • 25%
Increase by over 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by over 10% • 25%
Increase by 5% or more • 25%
Increase by less than 5% • 25%
Decrease • 25%
No significant change • 25%
Stock price increases by 10% or more • 25%
Stock price decreases by 10% or more • 25%
Stock price remains within 10% of current value • 25%
Stock price fluctuates but no clear trend • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Less than 500 • 25%
More than 2000 • 25%
1001-2000 • 25%
500-1000 • 25%